Zealand Pharma A/S (ZEAL) — Capital Reinvestment Ratio
Zealand Pharma A/S (ZEAL) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (Dkr8.52 Billion) in capital expenditures (Dkr6.73 Million). Check Zealand Pharma A/S tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zealand Pharma A/S Capital Reinvestment Ratio (2012–2025)
This chart tracks Zealand Pharma A/S's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see ZEAL cash flow metrics.
Annual Capital Reinvestment Ratio for Zealand Pharma A/S (2012–2025)
Year-by-year Capital Reinvestment Ratio for Zealand Pharma A/S from 2012 to 2025. See ZEAL free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | Dkr6.53 Billion | Dkr33.37 Million | ▼ -92.0% |
| 2016 | 0.06x | Dkr40.90 Million | Dkr2.60 Million | ▼ -50.8% |
| 2012 | 0.13x | Dkr68.54 Million | Dkr8.85 Million | — |